Limit the time the medication spends outside the refrigerator
Most of the excitement around it stems from advanced clinical trials that have shown substantial weight loss
This article explains why oral administration is not feasible, what current research into oral GLP-1 therapies looks like, and how to discuss licensed weight management options safely with your GP
Rapid patient acquisition outpaces support infrastructure buildout
Fibrosis Prevention: By clearing fat from the liver cells (hepatocytes), Retatrutide may prevent the progression to MASH (Steatohepatitis) and eventual cirrhosis, potentially reducing the need for liver transplants in the future
The EHR cohort was younger and had a larger proportion of men than the survey cohort (median age 44 years versus 52 years, and 37% male versus 18%), and both of these factors may contribute to some of the apparent difference in weight loss efficacy between self-report and EHR data